Research Solutions (NASDAQ:RSSS – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Thursday, May 9th. Analysts expect Research Solutions to post earnings of $0.02 per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link.
Research Solutions Trading Down 1.4 %
NASDAQ RSSS opened at $2.84 on Tuesday. The stock has a market cap of $92.64 million, a P/E ratio of -144.00 and a beta of 0.62. The company’s fifty day simple moving average is $3.09 and its 200-day simple moving average is $2.76. Research Solutions has a 52 week low of $1.80 and a 52 week high of $3.50.
Insider Buying and Selling at Research Solutions
In other news, major shareholder Peter Derycz sold 40,402 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $2.87, for a total transaction of $115,953.74. Following the completion of the sale, the insider now owns 2,984,680 shares of the company’s stock, valued at $8,566,031.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 26.47% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on RSSS
About Research Solutions
Research Solutions, Inc, through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle.
Further Reading
- Five stocks we like better than Research Solutions
- The Most Important Warren Buffett Stock for Investors: His Own
- Hims & Hers Health Stock Could Become a Wealth Compounder
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Penny Stocks That Insiders Are Buying
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Traders Sell but Investors Still Win After Palantir’s Earnings
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
